Metallo-Therapy

Gold Nanoparticles for Cancer Management

Health Tech & Life Sciences
Non Active, Sep 2016 ceased to operate
Seed Nazareth, Israel Founded 2010
Last updated 2026-06-18
Total raised
—
Last: Undisclosed Round 2011-05
Stage
Seed
Founded
2010
Headcount
—
HQ
Nazareth, Israel
Sector
Health Tech & Life Sciences

About

Metallo-Therapy (MT) is developing contrast agents that enable precise tumor detection and monitoring using CT imaging. MT's proprietary gold nanoparticles (GNP) accumulate in malignant tumors and remain therefor a few weeks. Due to their low toxicity and contrasting function, the GNPs can function as nano-markers, supporting and enhancing multiple applications in the management of cancer patients undergoing radiotherapy. Metallo-Therapy is supported by the Chief Scientist of the Israeli Ministry of Economy and by Arkin Holdings, an investment fund focused on innovative technologies in the healthcare market.

Offices

Nazareth, Israel · HQ / main office

Q&A

What is Metallo-Therapy's primary focus?
Metallo-Therapy is developing contrast agents using gold nanoparticles for precise tumor detection and monitoring with CT imaging, primarily for cancer management.
When was Metallo-Therapy founded?
Metallo-Therapy was founded in January 2010.
What is the current status of Metallo-Therapy?
Metallo-Therapy is currently inactive, having ceased operations in September 2016.
How much funding has Metallo-Therapy raised in total?
Metallo-Therapy has raised a total of $4,000,000.
Which investor participated in Metallo-Therapy's funding round?
Arkin Tech participated in Metallo-Therapy's funding round in May 2011.
How many employees did Metallo-Therapy have?
Metallo-Therapy had 1-10 employees.
Who is the founder of Metallo-Therapy?
Dr. Amal Ayoub is the founder of Metallo-Therapy.
What is Metallo-Therapy's primary sector?
Metallo-Therapy's primary sector is Health Tech & Life Sciences.

Sectors & technology

Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesMedical DevicesDiagnostics Devices
Technologies
Simulation & Imaging
Target customers
Healthcare & Life SciencesHealthcareProviders
Business model
B2B

Highlights

1 PatentsVerified

Tags

imagingradiologyhospitalsdetectioncancermedical-technologiesx-raydiagnostics
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)

Identifiers & details

Founded2010-1
Status reasonNon Active, Sep 2016 ceased to operate